Danaher Corporation (NYSE:DHR) CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $92.64, for a total transaction of $11,671,620.96. Following the completion of the sale, the chief executive officer now directly owns 271,737 shares of the company’s stock, valued at $25,173,715.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Danaher Corporation (NYSE:DHR) last posted its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 EPS for the quarter, beating the consensus estimate of $0.95 by $0.05. The company had revenue of $4.53 billion during the quarter, compared to analysts’ expectations of $4.47 billion. Danaher Corporation had a return on equity of 11.29% and a net margin of 13.36%. The firm’s revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.87 EPS.

The firm also recently declared a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were issued a $0.14 dividend. This represents a $0.56 annualized dividend and a yield of 0.61%. The ex-dividend date of this dividend was Thursday, September 28th. Danaher Corporation’s dividend payout ratio (DPR) is 16.52%.

WARNING: This report was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://www.americanbankingnews.com/2017/11/02/thomas-patrick-joyce-jr-sells-125989-shares-of-danaher-corporation-dhr-stock.html.

DHR has been the subject of a number of analyst reports. Morgan Stanley increased their price objective on shares of Danaher Corporation from $95.00 to $98.00 and gave the stock an “overweight” rating in a research note on Friday, October 20th. Wells Fargo & Company initiated coverage on shares of Danaher Corporation in a research note on Thursday, July 13th. They issued a “market perform” rating and a $90.00 price objective for the company. Credit Suisse Group increased their price objective on shares of Danaher Corporation from $93.00 to $96.00 and gave the stock an “outperform” rating in a research note on Friday, October 20th. Goldman Sachs Group, Inc. (The) reissued a “neutral” rating and issued a $83.00 price objective on shares of Danaher Corporation in a research note on Tuesday, September 26th. Finally, Zacks Investment Research raised shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price objective for the company in a research note on Thursday, October 5th. One analyst has rated the stock with a sell rating, four have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $93.31.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Norway Savings Bank grew its holdings in Danaher Corporation by 0.4% in the 2nd quarter. Norway Savings Bank now owns 2,238 shares of the conglomerate’s stock valued at $189,000 after buying an additional 10 shares during the period. National Asset Management Inc. grew its holdings in Danaher Corporation by 0.4% in the 2nd quarter. National Asset Management Inc. now owns 3,767 shares of the conglomerate’s stock valued at $318,000 after buying an additional 14 shares during the period. First Financial Corp IN grew its holdings in Danaher Corporation by 0.8% in the 2nd quarter. First Financial Corp IN now owns 2,720 shares of the conglomerate’s stock valued at $230,000 after buying an additional 21 shares during the period. Brighton Jones LLC grew its holdings in Danaher Corporation by 0.4% in the 2nd quarter. Brighton Jones LLC now owns 5,159 shares of the conglomerate’s stock valued at $435,000 after buying an additional 21 shares during the period. Finally, Guardian Life Insurance Co. of America grew its holdings in Danaher Corporation by 1.0% in the 1st quarter. Guardian Life Insurance Co. of America now owns 2,356 shares of the conglomerate’s stock valued at $202,000 after buying an additional 24 shares during the period. Institutional investors own 75.49% of the company’s stock.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Insider Buying and Selling by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.